Aju Ib Investment Co., Ltd. - Net Worth and Insider Trading

Aju Ib Investment Co., Ltd. Net Worth

The estimated net worth of Aju Ib Investment Co., Ltd. is at least $187,893 dollars as of 2024-11-07. Aju Ib Investment Co., Ltd. is the 10% Owner of Aileron Therapeutics Inc and owns about 50,509 shares of Aileron Therapeutics Inc (ALRN) stock worth over $187,893. Details can be seen in Aju Ib Investment Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aju Ib Investment Co., Ltd. has not made any transactions after 2017-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Aju Ib Investment Co., Ltd.

To

Aju Ib Investment Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aju Ib Investment Co., Ltd. owns 2 companies in total, including Apellis Pharmaceuticals Inc (APLS) , and Aileron Therapeutics Inc (ALRN) .

Click here to see the complete history of Aju Ib Investment Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Aju Ib Investment Co., Ltd.

Ticker Comapny Transaction Date Type of Owner
APLS Apellis Pharmaceuticals Inc 2017-11-08 10 percent owner
ALRN Aileron Therapeutics Inc 2017-07-05 10 percent owner

Aju Ib Investment Co., Ltd. Latest Holdings Summary

Aju Ib Investment Co., Ltd. currently owns a total of 1 stock. Aju Ib Investment Co., Ltd. owns 50,509 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $187,893.

Latest Holdings of Aju Ib Investment Co., Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALRN Aileron Therapeutics Inc 2017-07-05 50,509 3.72 187,893

Holding Weightings of Aju Ib Investment Co., Ltd.


Aju Ib Investment Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Aju Ib Investment Co., Ltd. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 1,246 shares on July 5, 2017, which cost Aju Ib Investment Co., Ltd. around $373,935.

Insider Trading History of Aju Ib Investment Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aju Ib Investment Co., Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Aju Ib Investment Co., Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aju Ib Investment Co., Ltd. is 18.28%. GuruFocus also compares Aju Ib Investment Co., Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Aju Ib Investment Co., Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Aju Ib Investment Co., Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Aju Ib Investment Co., Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Aju Ib Investment Co., Ltd. Ownership Network

Ownership Network List of Aju Ib Investment Co., Ltd.

No Data

Ownership Network Relation of Aju Ib Investment Co., Ltd.

Insider Network Chart

Aju Ib Investment Co., Ltd. Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Aju Ib Investment Co., Ltd. is the 10 percent owner of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Aju Ib Investment Co., Ltd. made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Aju Ib Investment Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Aju Ib Investment Co., Ltd.. You might contact Aju Ib Investment Co., Ltd. via mailing address: 5f, Aju Building, 201 Teheran-ro, Gangnam-gu, Seoul M5 06141.